RYCYX
Price
$150.97
Change
+$0.96 (+0.64%)
Updated
Aug 27 closing price
Net Assets
47.18M
RYVLX
Price
$638.68
Change
+$2.01 (+0.32%)
Updated
Aug 27 closing price
Net Assets
1.19B
Interact to see
Advertisement

RYCYX vs RYVLX

Header iconRYCYX vs RYVLX Comparison
Open Charts RYCYX vs RYVLXBanner chart's image
Rydex Dow 2x Strategy C
Price$150.97
Change+$0.96 (+0.64%)
VolumeN/A
Net Assets47.18M
Rydex NASDAQ-100® 2x Strategy A
Price$638.68
Change+$2.01 (+0.32%)
VolumeN/A
Net Assets1.19B
RYCYX vs RYVLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RYCYX vs. RYVLX commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYCYX is a StrongBuy and RYVLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.19B vs. RYCYX (47.2M). RYCYX pays higher dividends than RYVLX: RYCYX (0.73) vs RYVLX (0.00). RYCYX was incepted earlier than RYVLX: RYCYX (22 years) vs RYVLX (21 years). RYCYX (2.62) is less costly to investors than RYVLX (1.87). RYCYX is a more actively managed with annual turnover of: 1015.00 vs. RYVLX (383.00). RYCYX (2500) and RYVLX (2500) have matching initial minimum investment requirements. RYVLX annual gain was more profitable for investors over the last year : 22.38 vs. RYCYX (9.00). RYVLX return over 5 years is better than : 97.47 vs. RYCYX (79.65).
RYCYXRYVLXRYCYX / RYVLX
Total Expense Ratio2.531.74145%
Annual Report Gross Expense Ratio2.621.87140%
Fund Existence22 years21 years-
Gain YTD8.00615.63851%
Front LoadN/A5%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets47.2M1.19B4%
Annual Yield % from dividends0.730.00-
Returns for 1 year9.0022.3840%
Returns for 3 years54.34141.5738%
Returns for 5 years79.6597.4782%
Returns for 10 years273.76775.7535%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAGMF0.130.02
+21.77%
MAGMA SILVER CORP.
CLVLF8.500.54
+6.80%
Clinuvel Pharmaceuticals Ltd.
CTTAF88.840.88
+1.00%
Continental AG
HAPVD10.01N/A
N/A
HAPVIDA PARTICIPACOES E INVESTIMENTOS SA
VMNT0.23-0.03
-11.50%
Vemanti Group Inc.